AKARI THERAPEUTICS PLC
A Revolution in Treating Complement
Treating Rare & Orphan
Inflammatory Diseases
Inflammatory Diseases
Akari is a clinical-stage biopharmaceutical company focused on developing inhibitors of acute and chronic inflammation, specifically the complement system, the eicosanoid system and the bioamine system.
Powered By Nature
Akari molecules are derived from ticks, where 300 million years of evolution has generated molecules which are well tolerated and target the human inflammatory system with exceptionally tight binding.
